Literature DB >> 4118359

Changes in the solubility of immunoglobulins after fluorescent labeling and its influence on immunofluorescent techniques.

W Arnold, H von Mayersbach.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4118359     DOI: 10.1177/20.12.975

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


× No keyword cloud information.
  14 in total

1.  Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue.

Authors:  A Trevisan; G Realdi; C Losi; V Ninfo; M Rugge; L Rampinelli
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

2.  In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.

Authors:  M Mondelli; A Alberti; F Tremolada; R Williams; A L Eddleston; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

3.  Localisation of e-antigen in nuclei of hepatocytes in HBsAg-positive liver diseases.

Authors:  W Arnold; J O Nielsen; F Hardt; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

4.  The fate of injected human IgG in the mouse liver: Uptake, immunological inactivation, and lysosomal reactions.

Authors:  D Mitrenga; W Arnold; O Müller; H V Mayersbach
Journal:  Cell Tissue Res       Date:  1975       Impact factor: 5.249

5.  Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis.

Authors:  A Alberti; G Realdi; F Tremolada; G P Spina
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

6.  Detection of immunoglobulins G and A on the cell membrane of hepatocytes from patients with alcoholic liver disease.

Authors:  A Trevisan; R Cavigli; R Meliconi; G F Stefanini; S Zotti; M Rugge; F Noventa; C Betterle; G Realdi
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

7.  Physicochemical and serological characteristics of respiratory virus fluorescein-isothiocyanate conjugates for fluorescent-antibody diagnosis.

Authors:  H C Lyerla; J C Hierholzer
Journal:  J Clin Microbiol       Date:  1975-05       Impact factor: 5.948

8.  Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases.

Authors:  K H Meyer zum Büschenfelde; A Alberti; W Arnold; J Freudenberg
Journal:  Klin Wochenschr       Date:  1975-11-15

9.  Studies on the pathogenesis of chronic inflammatory liver diseases. I. Membrane-fixed IgG on isolated hepatocytes from patients.

Authors:  U Hopf; W Arnold; K H Meyer zum Büschenfelde; E Förster; J P Bolte
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

10.  Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases.

Authors:  W Arnold; G Hess; R H Purcell; P M Kaplan; J L Gerin; K H Meyer
Journal:  Klin Wochenschr       Date:  1978-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.